tiprankstipranks
ReNeuron Group plc (RNUGF)
OTHER OTC:RNUGF

ReNeuron Group (RNUGF) Stock Price & Analysis

6 Followers

RNUGF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.03 - $0.12
Previous Close$0.04
Volume2.00K
Average Volume (3M)2.00K
Market Cap
$2.46M
Enterprise Value-$6.16M
Total Cash (Recent Filing)£7.15M
Total Debt (Recent Filing)£421.00K
Price to Earnings (P/E)-0.4
Beta0.28
Jul 11, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-0.11
Shares Outstanding57,173,760
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Standard Deviation0.39
R-Squared0.00707
Alpha-0.00187
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)4.58
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

19.88%0.00%<0.01%80.11%
19.88% Insiders
<0.01% Other Institutional Investors
80.11% Public Companies and
Individual Investors

RNUGF FAQ

What was ReNeuron Group plc’s price range in the past 12 months?
ReNeuron Group plc lowest stock price was $0.03 and its highest was $0.12 in the past 12 months.
    What is ReNeuron Group plc’s market cap?
    Currently, no data Available
    When is ReNeuron Group plc’s upcoming earnings report date?
    ReNeuron Group plc’s upcoming earnings report date is Jul 11, 2024 which is in 105 days.
      How were ReNeuron Group plc’s earnings last quarter?
      ReNeuron Group plc released its earnings results on Nov 08, 2023. The company reported -$0.064 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.064.
        Is ReNeuron Group plc overvalued?
        According to Wall Street analysts ReNeuron Group plc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does ReNeuron Group plc pay dividends?
          ReNeuron Group plc does not currently pay dividends.
          What is ReNeuron Group plc’s EPS estimate?
          ReNeuron Group plc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does ReNeuron Group plc have?
          ReNeuron Group plc has 57,173,760 shares outstanding.
            What happened to ReNeuron Group plc’s price movement after its last earnings report?
            ReNeuron Group plc reported an EPS of -$0.064 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of ReNeuron Group plc?
              Currently, no hedge funds are holding shares in RNUGF
              ---

              ReNeuron Group Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -65.57%
              12-Months-Change

              Fundamentals

              Return on Equity
              -114.91%
              Trailing 12-Months
              Asset Growth
              -49.21%
              Trailing 12-Months

              Company Description

              ReNeuron Group plc

              ReNeuron Group Plc engages in the development of novel cell based therapies that target significant areas of unmet medical need. It develops its core stem cell assets such as CTX neural cell line and human retinal progenitor cells. The company was founded by John David Sinden in 1997 and is headquartered in Pencoed, the United Kingdom.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              CytoDyn
              Brainstorm Cell Therapeutics
              Mesoblast
              Oncolytics Biotech
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis